Treatment of Older Adult Acute Myeloid Leukemia Patients Aged 55 to 65 Years

NCT02432872 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

300

Enrollment

UNKNOWN

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Daunorubicin
DRUG: Cytarabine

Sponsor

Jianxiang Wang